Turkish Adult Risk Factor survey 2013: rapid rise in the prevalence of diabetes

Basit Öğe Kaydı
dc.contributor.authorOnat, Altan
dc.contributor.authorCakir, Hakan
dc.contributor.authorKaradeniz, Yusuf
dc.contributor.authorDomez, Ibrahim
dc.contributor.authorKaragoz, Ahmet
dc.contributor.authorYuksel, Murat
dc.contributor.authorCan, Gunay
dc.date.accessioned2024-04-24T17:27:49Z
dc.date.available2024-04-24T17:27:49Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjectives: To analyze (1) the sex-specific and age-bracket defned all-cause and coronary mortality in the 23-years' follow-up of the Turkish Adult Risk Factor Study, and (2) to determine the nation-wide prevalence of Type-2 diabetes and its recent trend. Study design: Information on the mode of death was obtained from frst-degree relatives and/or health personnel of local heath offce. Information collected from survivors was based on history, physical examination of the cardiovascular system and Minnesota coding of resting electrocardiograms. Diabetes was defned by criteria of the American Diabetes Association without the use of glycated hemoglobin. Results: Of the 1370 participants to be surveyed, 768 were examined, in 452 subjects information was gathered, and 29 men, 18 women were ascertained to have died. Cumulative assessment of the entire cohort in the age bracket of 45-74 years disclosed coronary mortality to be 7.5/1000 personyears in men and 3.74 in women, persisting to be high among the European countries. The recent decline observed in overall mortality seemed to halt as well. Of greatest concern was the fnding in the past 12 years that the rate of rise in the age-controlled prevalence of Type-2 diabetes was as high as 5% annually. Conclusion: Overall and coronary mortality in Turkish adults continue to be high, while an elicited annual increase of 5% in the age-controlled prevalence of diabetes is virtually alarming and requires new public health policies.en_US
dc.description.sponsorshipAstraZeneca firmen_US
dc.description.sponsorshipWe thank AstraZeneca firm for unconditional partial support it provided for the 2013 TEKHARF survey.en_US
dc.identifier.doi10.5543/tkda.2014.27543
dc.identifier.endpage516en_US
dc.identifier.issn1016-5169
dc.identifier.issue6en_US
dc.identifier.pmid25362940
dc.identifier.scopus2-s2.0-84931060885
dc.identifier.scopusqualityQ3
dc.identifier.startpage511en_US
dc.identifier.urihttps://doi.org/10.5543/tkda.2014.27543
dc.identifier.urihttps://hdl.handle.net/11468/20210
dc.identifier.volume42en_US
dc.identifier.wosWOS:000421948900003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isotren_US
dc.publisherTurkish Soc Cardiologyen_US
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivi-Archives of The Turkish Society of Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDiabetes Mellitusen_US
dc.subjectCoronary Disease/Mortalityen_US
dc.subjectMortality/Trendsen_US
dc.subjectTurkey/Epidemiologyen_US
dc.titleTurkish Adult Risk Factor survey 2013: rapid rise in the prevalence of diabetesen_US
dc.titleTurkish Adult Risk Factor survey 2013: rapid rise in the prevalence of diabetes
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu